WHO ICTRP trial

A Bioequivalence study of a randomized, open-label, single dose, two-way…

TCTR20230915001 · Thai Clinical Trials Registry (TCTR) · Not Recruiting

Key facts

Trial ID TCTR20230915001
Public title A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Linagliptin 2.5 mg and Metformin 500 mg Tablets relative to Trajenta Duo Tablets 2.5 mg/500 mg in Thai healthy volunteers under fed condition
Scientific title A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Linagliptin 2.5 mg and Metformin 500 mg Film-coated Tablets relative to Trajenta Duo Film-coated Tablets 2.5 mg/500 mg in Thai healthy volunteers under fed…
Primary sponsor Bio-innova Co., Ltd.
Registry Thai Clinical Trials Registry (TCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 1
Countries Thailand
Conditions Healthy subjects Bioequivalence Linagliptin 2.5 mg and Metformin 500 mg film-coated tablets;Bioequivalence Linagliptin 2.5 mg and Metformin 500 mg film-coated tablets
Interventions The new generic products which were recently developed. Volunteer will receive a single dose of Linagliptin 2.5 mg and Metformin 500 mg Film-coated tablets with 240 mL of 20% glucose solution in water within 30 mins, The marketed original…
Registration date Sep 15, 2023
Target size 40
Secondary IDs Nil Known
Registry page thaiclinicaltrials.org

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations